Convulsion syndrome, simulating tetanus, during treatment with droperidol and haloperidol
Rodin, G.D.
Sovetskaia Meditsina 11: 149-150
1974
ISSN/ISBN: 0038-5077 PMID: 4439069 Document Number: 73655
Document emailed within 1 workday
Related Documents
Langer, G.; Pühringer, W. 1980: Haloperidol and droperidol treatment in schizophrenics. Clinical application of the "prolactin-model" Acta Psychiatrica Belgica 80(5): 574-583Kipper, R.; Helmer, J.; Vivin, P.; Fossard, J.P.; Sicard, A.; Thome, M. 1987: Recovery following neuroleptanalgesia with droperidol-alfentanyl and droperidol-fentanyl Cahiers d'Anesthesiologie 35(8): 631-634
Pladys, P.; Roussey, M.; Dabadie, A.; Betremieux, P.; Lefrançois, C. 1991: Post-vaccinal hemi-convulsion hemiplegia syndrome Annales de Pediatrie 38(9): 602-604
Chopra, K.; Gupta, A.; Mhatre, K. 1986: Intrathecal tetanus hyperimmune human gamma globulin in the treatment of tetanus Indian Pediatrics 23(10): 775-778
Quevedo Arechederra, M.A.; Aguilera Celorrio, L.J. 1985: Extrapyramidal syndrome as an adverse reaction to droperidol Revista Espanola de Anestesiologia y Reanimacion 32(3): 133-134
Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40
Nagao, M.; Kanamori, M.; Takatori, T.; Terazawa, K.; Gotouda, H. 1987: An attempt on removal of haloperidol in plasma by use of anti-haloperidol immunoadsorbent Nihon Hoigaku Zasshi 41(3): 232-235
Lukić, I.; Marinković, E.; Filipović, A.; Krnjaja, O.; Kosanović, D.; Inić-Kanada, A.; Stojanović, M. 2015: Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction Toxicon: Official Journal of the International Society on Toxinology 103: 135-144
Lowry, R.B.; Guichon, V.C. 1972: Congenital contractural arachnodactyly: a syndrome simulating Marfan's syndrome Canadian Medical Association Journal 107(6): 531 Passim
Amielańczyk, W. 1973: Delirious syndrome following administration of haloperidol Psychiatria Polska 7(2): 218-221
Rasstrigin, N.N.; Ivanov, I.P.; Zverev, V.V.; Krasil'nikova, A.I. 1973: Treatment of vomiting in pregnancy by droperidol Voprosy Okhrany Materinstva i Detstva 18(11): 65-69
Komarov, F.I.; Ol'binskaia, L.I.; Enikeeva, N.B.; Ovasapian, I.A. 1978: Treatment of hypertensive crises with droperidol Klinicheskaia Meditsina 56(10): 25-29
Kulikova, O.N.; Tarakanov, A.V. 1982: Protein metabolic status of acute myocardial infarct patients before and after fentanyl and droperidol arrest of the pain syndrome Farmakologiia i Toksikologiia 45(4): 52-54
Sherman, D.M.; Tsygura, I.T.; Kolomiĭtsev, V.I. 1984: Noradrenaline and droperidol in the treatment of hemorrhagic shock Voenno-Meditsinskii Zhurnal 1: 52-54
Jones, F.G.; Moss, J.M. 1937: Studies on tetanus toxoid. II. The response of human subjects to an injection of tetanus toxoid or tetanus alum precipitated toxoid one year after immunization Jour Immunol 33(3): 183-190
Singer, H.S.; Rabins, P.; Tune, L.E.; Coyle, J.T. 1981: Serum haloperidol levels in Gilles de la Tourette syndrome Biological Psychiatry 16(1): 79-84
Samar, R.K.; Kaushik, S.K.; Garg, A.R. 1983: Malignant neuroleptic syndrome due to haloperidol. (A case report) Journal of Postgraduate Medicine 29(1): 56-58
Korzh, O.B. 1979: Use of phentanyl with droperidol or seduxen in nitrous oxide anesthesia in patients with blood vessel diseases of the lower extremities accompanied by pain syndrome Klinicheskaia Khirurgiia 2: 68-69
Chen, C.C.; Chen, S.S.; Wen, J.K. 1985: Neuroleptic malignant syndrome and myopathy: a case report of lithium and haloperidol intoxication Journal of the Formosan Medical Association 84(12): 1371-1379
Levit, A.L.; Popov, A.A.; Piontek, E.V. 1978: Use of droperidol and seduxen for preanesthetic medication in surgical treatment of mitral valve stenosis Vestnik Khirurgii Imeni I. I. Grekova 120(3): 71-73